SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,808.35 |
| Enterprise Value ($M) | 2,219.76 |
| Book Value ($M) | 1,503.38 |
| Book Value / Share | 12.60 |
| Price / Book | 2.53 |
| NCAV ($M) | 1,484.47 |
| NCAV / Share | 12.44 |
| Price / NCAV | 2.57 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.19 |
| Return on Assets (ROA) | -0.45 |
| Return on Equity (ROE) | -0.56 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 17.76 |
| Current Ratio | 17.76 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,621.87 |
| Assets | 1,640.77 |
| Liabilities | 137.39 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ra Capital Management, L.p. | 5.40 | 28.69 | |
| 13G | Avoro Capital Advisors LLC | 8.30 | ||
| 13G/A | Price T Rowe Associates Inc /md/ | 9.00 | 10.12 | |
| 13G/A | Cowen Financial Products LLC | 0.00 | -100.00 | |
| 13G/A | Bristol Myers Squibb Co | 4.30 | 0.00 | |
| 13G/A | Vanguard Group Inc | 7.84 | 0.00 | |
| 13G | Wellington Management Group Llp | 5.97 | ||
| 13D/A | Rtw Investments, Lp | 25.05 | ||
| 13G/A | Fmr Llc | 14.04 | -2.06 | |
| 13G/A | BlackRock, Inc. | 8.80 | 22.90 | |
| 13G/A | State Street Corp | 4.64 | -3.69 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 214,230 | 716,490 | 29.90 | |
| 289,379 | 918,550 | 31.50 | |
| 313,332 | 1,291,079 | 24.27 | |
| 191,813 | 1,024,428 | 18.72 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RAPT – RAPT Therapeutics, Inc. | RCKT – Rocket Pharmaceuticals, Inc. |
| RLAY – Relay Therapeutics, Inc. | RNAC – Cartesian Therapeutics, Inc. |
| RVNC – Revance Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io